Qiagen NV [QGEN] stock prices are down -1.56% to $50.98 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The QGEN shares have gain 6.08% over the last week, with a monthly amount glided 6.12%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Qiagen NV [NYSE: QGEN] stock has seen the most recent analyst activity on June 24, 2025, when Barclays initiated its Overweight rating and assigned the stock a price target of $55. Previously, Redburn Atlantic downgraded its rating to Neutral on April 04, 2025. On February 19, 2025, downgrade downgraded it’s rating to Neutral and revised its price target to $42 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight but stick to its price target of $48 on January 06, 2025. Jefferies upgraded its rating to a Buy and raised its price target to $54 on December 10, 2024. HSBC Securities downgraded its rating to Hold for this stock on October 17, 2024, but kept the price target unchanged to $49. In a note dated June 27, 2024, Wolfe Research upgraded an Outperform rating on this stock but restated the target price of $50.
The stock price of Qiagen NV [QGEN] has been fluctuating between $37.63 and $51.88 over the past year. Currently, Wall Street analysts expect the stock to reach $51.89 within the next 12 months. Qiagen NV [NYSE: QGEN] shares were valued at $50.98 at the most recent close of the market. An investor can expect a potential return of 1.79% based on the average QGEN price forecast.
Analyzing the QGEN fundamentals
The Qiagen NV [NYSE:QGEN] reported sales of 2.00B for trailing twelve months, representing a surge of 5.37%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.05%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.41.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 50.68 points at the first support level, and at 50.39 for the second support level. However, for the 1st resistance point, the stock is sitting at 51.30, and for the 2nd resistance point, it is at 51.63.
Ratios To Look Out For
It’s worth pointing out that Qiagen NV [NYSE:QGEN]’s Current Ratio is 3.37. In addition, the Quick Ratio stands at 2.83 and the Cash Ratio stands at 1.24. Considering the valuation of this stock, the price to sales ratio is 5.51, the price to book ratio is 3.24 and price to earnings (TTM) ratio is 122.14.
Transactions by insiders
Recent insider trading involved Sackers Roland, Officer, that happened on Sep 11 ’24 when 25000.0 shares were purchased.
